US Stock MarketDetailed Quotes

CTNM Contineum Therapeutics

Watchlist
  • 20.060
  • +1.820+9.98%
Close Aug 23 16:00 ET
  • 20.060
  • 0.0000.00%
Post 20:01 ET
516.01MMarket Cap-26119P/E (TTM)

Contineum Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(FY)Dec 31, 2021
Total revenue
0
0
50M
0
0
50M
0
0
0
0
Operating revenue
--0
--0
--50M
--0
--0
--50M
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-1.08%10.94M
94.13%9.93M
49.31%33.92M
77.57%9.68M
8.07M
11.06M
5.12M
-20.69%22.72M
5.45M
28.65M
Selling and administrative expenses
89.83%3.04M
45.11%2.15M
8.48%6.32M
11.30%1.66M
--1.57M
--1.6M
--1.48M
-7.33%5.83M
--1.5M
--6.29M
-General and administrative expense
89.83%3.04M
45.11%2.15M
8.48%6.32M
11.30%1.66M
--1.57M
--1.6M
--1.48M
-7.33%5.83M
--1.5M
--6.29M
Research and development costs
-16.48%7.9M
114.15%7.78M
63.39%27.6M
102.63%8.01M
--6.5M
--9.46M
--3.63M
-24.45%16.89M
--3.95M
--22.36M
Operating profit
-128.11%-10.94M
-94.13%-9.93M
170.76%16.08M
-77.57%-9.68M
-8.07M
38.94M
-5.12M
20.69%-22.72M
-5.45M
-28.65M
Net non-operating interest income expense
255.42%2M
429.45%1.64M
1,079.09%4.4M
642.74%1.79M
1.74M
563K
309K
246.27%373K
241K
-255K
Non-operating interest income
194.70%2M
307.98%1.64M
505.26%4.61M
423.39%1.79M
--1.74M
--679K
--401K
888.31%761K
--342K
--77K
Non-operating interest expense
--0
--0
-46.39%208K
--0
--0
--116K
--92K
16.87%388K
--101K
--332K
Other net income (expense)
-102.36%-66K
-583.33%-123K
241.40%2.7M
98.09%-44K
-36K
2.79M
-18K
-1,825.25%-1.91M
-2.3M
-99K
Gain on sale of security
450.00%11K
---117K
66.67%5K
200.00%3K
--0
--2K
----
50.00%3K
---3K
--2K
Special income (charges)
--0
----
257.79%2.87M
--0
--0
--2.87M
----
-18,070.00%-1.82M
---2.29M
---10K
-Less:Other special charges
----
----
-257.79%-2.87M
--0
--0
---2.87M
----
18,070.00%1.82M
--2.29M
--10K
Other non- operating income (expenses)
-1.32%-77K
66.67%-6K
-92.39%-177K
-370.00%-47K
---36K
---76K
---18K
-1.10%-92K
---10K
---91K
Income before tax
-121.30%-9.01M
-74.48%-8.42M
195.53%23.17M
-5.56%-7.93M
-6.37M
42.29M
-4.82M
16.37%-24.25M
-7.51M
-29M
Income tax
0
0
450K
-161K
-118K
729K
0
0
0
Net income
-121.68%-9.01M
-74.48%-8.42M
193.68%22.72M
-3.42%-7.77M
-6.25M
41.56M
-4.82M
16.37%-24.25M
-7.51M
-29M
Net income continuous Operations
-121.68%-9.01M
-74.48%-8.42M
193.68%22.72M
-3.42%-7.77M
---6.25M
--41.56M
---4.82M
16.37%-24.25M
---7.51M
---29M
Minority interest income
Net income attributable to the parent company
-121.68%-9.01M
-74.48%-8.42M
193.68%22.72M
-3.42%-7.77M
-6.25M
41.56M
-4.82M
16.37%-24.25M
-7.51M
-29M
Preferred stock dividends
Other preferred stock dividends
0
35.7M
Net income attributable to common stockholders
-253.50%-9.01M
-74.48%-8.42M
193.68%22.72M
-3.42%-7.77M
24.97M
5.87M
-4.82M
16.37%-24.25M
-7.51M
-29M
Basic earnings per share
-210.80%-0.39
-7.53%-0.3111
193.50%1.36
36.26%-0.2871
0.9228
0.352
-0.2893
16.37%-1.4545
-0.4505
-1.7393
Diluted earnings per share
-334.88%-0.39
-7.53%-0.3111
177.00%1.12
36.26%-0.2871
0.9228
0.166
-0.2893
16.37%-1.4545
-0.4505
-1.7393
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(FY)Dec 31, 2021
Total revenue 0050M0050M0000
Operating revenue --0--0--50M--0--0--50M--0--0--0--0
Cost of revenue
Gross profit
Operating expense -1.08%10.94M94.13%9.93M49.31%33.92M77.57%9.68M8.07M11.06M5.12M-20.69%22.72M5.45M28.65M
Selling and administrative expenses 89.83%3.04M45.11%2.15M8.48%6.32M11.30%1.66M--1.57M--1.6M--1.48M-7.33%5.83M--1.5M--6.29M
-General and administrative expense 89.83%3.04M45.11%2.15M8.48%6.32M11.30%1.66M--1.57M--1.6M--1.48M-7.33%5.83M--1.5M--6.29M
Research and development costs -16.48%7.9M114.15%7.78M63.39%27.6M102.63%8.01M--6.5M--9.46M--3.63M-24.45%16.89M--3.95M--22.36M
Operating profit -128.11%-10.94M-94.13%-9.93M170.76%16.08M-77.57%-9.68M-8.07M38.94M-5.12M20.69%-22.72M-5.45M-28.65M
Net non-operating interest income expense 255.42%2M429.45%1.64M1,079.09%4.4M642.74%1.79M1.74M563K309K246.27%373K241K-255K
Non-operating interest income 194.70%2M307.98%1.64M505.26%4.61M423.39%1.79M--1.74M--679K--401K888.31%761K--342K--77K
Non-operating interest expense --0--0-46.39%208K--0--0--116K--92K16.87%388K--101K--332K
Other net income (expense) -102.36%-66K-583.33%-123K241.40%2.7M98.09%-44K-36K2.79M-18K-1,825.25%-1.91M-2.3M-99K
Gain on sale of security 450.00%11K---117K66.67%5K200.00%3K--0--2K----50.00%3K---3K--2K
Special income (charges) --0----257.79%2.87M--0--0--2.87M-----18,070.00%-1.82M---2.29M---10K
-Less:Other special charges ---------257.79%-2.87M--0--0---2.87M----18,070.00%1.82M--2.29M--10K
Other non- operating income (expenses) -1.32%-77K66.67%-6K-92.39%-177K-370.00%-47K---36K---76K---18K-1.10%-92K---10K---91K
Income before tax -121.30%-9.01M-74.48%-8.42M195.53%23.17M-5.56%-7.93M-6.37M42.29M-4.82M16.37%-24.25M-7.51M-29M
Income tax 00450K-161K-118K729K000
Net income -121.68%-9.01M-74.48%-8.42M193.68%22.72M-3.42%-7.77M-6.25M41.56M-4.82M16.37%-24.25M-7.51M-29M
Net income continuous Operations -121.68%-9.01M-74.48%-8.42M193.68%22.72M-3.42%-7.77M---6.25M--41.56M---4.82M16.37%-24.25M---7.51M---29M
Minority interest income
Net income attributable to the parent company -121.68%-9.01M-74.48%-8.42M193.68%22.72M-3.42%-7.77M-6.25M41.56M-4.82M16.37%-24.25M-7.51M-29M
Preferred stock dividends
Other preferred stock dividends 035.7M
Net income attributable to common stockholders -253.50%-9.01M-74.48%-8.42M193.68%22.72M-3.42%-7.77M24.97M5.87M-4.82M16.37%-24.25M-7.51M-29M
Basic earnings per share -210.80%-0.39-7.53%-0.3111193.50%1.3636.26%-0.28710.92280.352-0.289316.37%-1.4545-0.4505-1.7393
Diluted earnings per share -334.88%-0.39-7.53%-0.3111177.00%1.1236.26%-0.28710.92280.166-0.289316.37%-1.4545-0.4505-1.7393
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg